Article info

Neurotoxicities in the treatment of HIV between dolutegravir, rilpivirine and dolutegravir/rilpivirine: a meta-analysis
Free

Authors

  1. Correspondence to Dr Anthony Allen Reeves, Department of Clinical and Administrative Sciences, Larkin University College of Pharmacy, Miami, FL 33169, USA; a.allenreeves13{at}gmail.com
View Full Text

Citation

Allen Reeves A, Fuentes AV, Caballero J, et al
Neurotoxicities in the treatment of HIV between dolutegravir, rilpivirine and dolutegravir/rilpivirine: a meta-analysis

Publication history

  • Received October 3, 2020
  • Revised January 4, 2021
  • Accepted January 7, 2021
  • First published March 29, 2021.
Online issue publication 
May 17, 2021

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.